KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Preferred Stock Liabilities: 2017-2018

Historic Preferred Stock Liabilities for Twist Bioscience (TWST) over the last 2 years, with Sep 2018 value amounting to $290.5 million.

  • Twist Bioscience's Preferred Stock Liabilities was N/A to $290.5 million in Q3 2018 from the same period last year, while for Sep 2018 it was $290.5 million, marking a year-over-year change of. This contributed to the annual value of $290.5 million for FY2018, which is 127.18% up from last year.
  • Twist Bioscience's Preferred Stock Liabilities amounted to $290.5 million in FY2018, which was up 127.18% from $127.9 million recorded in FY2017.
  • In the past 5 years, Twist Bioscience's Preferred Stock Liabilities ranged from a high of $290.5 million in FY2018 and a low of $127.9 million during FY2017.
  • Over the past 2 years, Twist Bioscience's median Preferred Stock Liabilities value was $209.2 million (recorded in 2017), while the average stood at $209.2 million.
  • Data for Twist Bioscience's Preferred Stock Liabilities shows a peak YoY spiked of 127.18% (in 2018) over the last 5 years.
  • Twist Bioscience's Preferred Stock Liabilities (Yearly) stood at $127.9 million in 2017, then spiked by 127.18% to $290.5 million in 2018.